gestation a female infant was born, after an otherwise uncomplicated pregnancy. She was severely SGA in all parameters, with a weight of 1030 grams. The Apgar scores were low, and respiratory problems required endotracheal intubation. She had signifant hypotonia and microcephaly with a sloping forehead and bitemporal narrowing. The faaal features were characteristic of Seckel syndrome, including down-slanted palpebral fissures, a prominent nose with a broad nasal tip, a small mouth with a thin upper lip, and micro-retrognathia. The ears were small, low set, and posteriorly rotated. She also had abnormal palmar creases, a deft palate, and hypoplastic labia. Postnatal study of peripheral blood lymphocytes confirmed the karyotype as 46.XX.r(4)(p16q35) 1241 1 45,X.-4 141. After discontinuation of the ventilator at age 18 days, she remained tachypneic on supplemental oxygen.
Feeding diffiwnies were encountered and nasogastnc feeds were instituted. Her weight gain was modest and at 33 days of l i e her weight was 1332 grams.
According to the literature, r(4) patlents phenotypically resemble WolfHirschhom syndrome. Co-existence of a r(4) chromosome with the Seckel syndrome phenotype was reported only once previously (Anderson CE et al: Am.J.Med.Genet. 72:281-5.1997 ). To explain this association, we are postulating that the locus of the Seckel syndrome gene might be on the distal arm of chromosome 4. In this scenario, a mutation of the gene on the normal chromosome 4, combined with the deletion of a normal allele on the r(4), could explatn the co-existence of Seckel syndrome and r(4) in these 2 cases. Molecular analyses of the deleted regions of chromosome 4 in classical Seckel syndrome patients may be warranted to prove that the association is not coincidental. Alternatively, the mosaic monosomy 4 (which has not been described previously in a livebom infant) could be causing the severe growth retardation It is less likely that this could explain the typical facial features of Seckel syndrome.
Chiari I malformation associated w~th a P250R mutation of FGFR3. L Te ', w. Advances in molecular studies have shown that mutations ~n the fibroblast growh factor receptor (FGFR) genes are responsible for six autosomal domlnmt craniosynostosis syndromes. Each FCFR has a common structure which Includes a conserved sequence that is thought to be critical for FGF blnding Mutations in this conserved region have been ident~fied in FGFRI. 2. and 3 and have been associated with classic craniosynostos~s syndromes, such as Pfeiffer and Apert syndromes. Recently, a new craniosynostosis syndrome has been described. This new syndrome is associated with a P250R mutation within the conserved region of FGFR3 This syndrome is characterized by synostosis (bilateral and unilateral), macrocephaly m the absence of synostosis, abnormalities of hands and feet. includ~ng broad b~g toes. brachydactyly, th~mble-like m~ddle phalanges, coned epiphyses, and carpal and tarsal fusions; sensorineural hearing loss; and developmental delay andlor mental retardallon. To further expand the phenotype of this specific mutation, we describe a six-month-old male infant with a P250R FGFR3 mutation and Chiari I malformation. Our patlent was born at 37 weeks gestation with a birth weight of 5 Ib. 9 oz. (15th percent~le for 37 weeks) and length of 18.75 Inches (50" percentile for 37 weeks) By SIX months of age, the patlent's height and weight were below the 5" percentile, wh~le his OFC remained ~n the normal range. The patlent's featwes include FTT, hypotonia, a large, patent anterior fontanelle, generous thumbs and great toes; h~gh arched palate. right parieteoccip~tal plagiocephaly, prominent occ~put, asymmetric mandible. low set and posteriorly rotated ears; and flat nasal br~dge. A skeletal survey was normal Head MRI revealed flanenlng of the right occipital skull with no ev~dence of definlte synostosis (CT scan of head has not been performed) The MRI study also revealed a Chiarl I malformat~on Subsequent molecular testing for the FGFRs ind~cated a P?5OR mutatlon of FGFR3 The patlent's mother had congenital hydrocephalus and placement of a V-P shunt. She also had leamlng problems In school Molecular testlng on the mother also Indicated a P250R mutatlon of FGFRJ In add~tion. the pat~ent's maternal grandmother IS reported to have a large head SIX w~th hydrocephalus Our case serves to further broaden the spectrum of the newly descr~bed crm~osynostos~s syndrome associated wlth the P250R mutatlon of FGFR3 Although many of the features present ~n th~s case have already becn documented. to our knowledge, the finding of Chiari I malformal~on. has not becn descr~bed and further expands the phenotype of th~s syndrome However, the following manifestations were found to be different: 3 o f 16
African-Americans and 3 o f 39 Caucasians were noted to have plexiform neuroma. None of the African-Americans were found to deveiop renal artery stenosis. although it was noted in 2 Caucasians. Three patients from the AfricanAmerican group were found to deveiop intracranial tumors other than optic glioma, although none o f the Caucasians were noted to have similar tumors in our sample. One explanation for these differences would be that AfricanAmericans might be getting medical attention only if they have significant problems such as plexiform neuroma or intracranial tumors. To better evaluate the prev~ously reported difference on the frequency o f optic glioma, we are collecting a larger sample currently including 84 African-Americans and 880 Caucasians. Thus far optic glioma has been diagnosed in 4 o f the 84 (4.8%) patients whose both parents were African-Americans and in 144 o f the 880 (16.4%) Caucasians (further analysis is continuing). Our results thus far suggest that the manifestations o f N F -l are somewhat d~fferent in African-Americans, a lower frequency of opt~c glioma being the most significant difference. Better understanding of clinical d~fferences in patlents with NF-I from different ethnic groups will help to identify modifying genetlc factors and to establish appropriate indlviduaiized diagnost~c and management plans.
Acampomelic campomel~c dysplasla w~th SOX9 mutation. Campomellc dysplas~a (CMPD. MIM 114290) is a rare dlsorder characterlsed by a dlstlnctive pattern of abnormal skeletal features and a generally lethal outcome as a result of respiratory dislress. Mutat~ons in the SOX9 gene are reported In affected chlldren with CMPD Acampomelic CMPD is a cllnlcal variant of the more commonly encountered CMPD but is characterlsed by absence of long bone curvature (acampomel~a). We report a one-year-old boy who presented at blrth with a flat fac~al profile with depressed nasal br~dge, mlcrognathia, cleft palate and m~crostomla, genltal findlngs conslstlng of bifid scrotum. permeal hypospadlas and undescended testes and tracheomalacia. Other abnorrnal~t~es Include a bifid k~dney. deep plantar creases and llm~ted elbow extension. Skeletal survey showed typical CMPD changes such as bilateral hypoplastlc scapulae. 11 pars of ribs, delayed bone age but without campomella.
M M
The patient's cond~tion gradually Improved over time. Both hls parents are well and not related. Genomlc analysis showed a de novo heterozygous mlssense rnulatlon K173E (AAG-tGAG; nucleot~de position 889) located wlthln the DNA blndlng HMG (h~gh mobllily group) domain of SOX9 gene. We postulated that thls mutallon is associated w~th res~dual actlv~ty of SOX9 proteln lead~ng to a m~lder phenotype or acampomel~c CMPD G e n e t i c s IN bbcjiiine
